5 nov 2019
CPhI Worldwide 2019
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Exhibitor at CPhI Worldwide 2019 stand 90B20, Finished Dosage Formulations

About us

Jiangsu Hansoh Pharmaceutical Co Ltd established in 1995, ranks among the top 10 pharmaceutical manufactures of China, which is the leading anticancer API manufacturer in China. With strong R&D and Regulatory supports, All APIs and finished drugs have China SFDA GMP Certificate, two APIs have US FDA and Japan PMDA approval, and one API hast Korea KFDA approval. In recent years Jiangsu Hansoh hasfocused on EU, US and Asia markets and we are looking forward to promoting great cooperative relationships with customers from all over the world.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Finished Dosage Forms More

Products featured at CPhI Worldwide 2019

Categories affiliated with Jiangsu Hansoh Pharmaceutical Co., Ltd.

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Event information

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 90B20